Istanbul Medipol University is a private university in Istanbul, Turkey. It was founded by Turkey Education Health and Research Foundation in 2009. The founder of the foundation is Fahrettin Koca, who is the current Minister of Health of Turkey.

During the past decade, Medipol University Medical Faculty conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medipol University Medical Faculty" #1 sponsor was "Ahmet Bilici" with 1 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medipol University Medical Faculty" #1 collaborator was "Acıbadem Atunizade Hospital" with 1 trials as a collaborator, "Akdeniz University" with 1 trials as a collaborator, "Ankara City Hospital Bilkent" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Medipol University Medical Faculty" are "Breast Cancer" (2 trials), "First Line Non-Small Cell Lung Cancer" (1 trials), "Lung Cancer" (1 trials), "Metastatic Nonsquamous Non-Small Cell Lung Cancer" (1 trials) and "Metastatic Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Medipol University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Medipol University Medical Faculty" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Pemetrexed" (3 trials), "Cisplatin" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medipol University Medical Faculty" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medipol University Medical Faculty". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medipol University Medical Faculty, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medipol University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".